Revolution Medicines Inc. (RVMD)
NASDAQ: RVMD
· Real-Time Price · USD
46.71
1.01 (2.21%)
At close: Oct 03, 2025, 3:59 PM
46.70
-0.02%
After-hours: Oct 03, 2025, 07:32 PM EDT
Revolution Medicines Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 742K | 742K | 4.57M | 11.58M | 26.17M | 29.52M | 34.82M | 35.38M | 29.51M | 27.25M | 26.84M | 29.39M | 28.68M | 40.24M | 41.57M |
Cost of Revenue | 549.4M | 558.37M | 470.64M | 419.13M | 375.11M | 369.98M | 320.9M | 250.45M | 212.17M | 265.53M | 253.07M | 240.63M | 217.65M | 202.58M | 186.95M | 170.27M | 158.67M | 145.65M |
Gross Profit | -549.4M | -558.37M | -470.64M | -418.39M | -374.37M | -365.41M | -309.32M | -224.28M | -182.65M | -230.71M | -217.69M | -211.12M | -190.39M | -175.74M | -157.56M | -141.59M | -118.43M | -104.08M |
Operating Income | -897.5M | -789.42M | -689.52M | -653.2M | -600.73M | -552.89M | -487.19M | -368.91M | -322.19M | -275.49M | -258.28M | -249.48M | -226.11M | -208.56M | -188.01M | -169.18M | -143.56M | -127.01M |
Interest Income | 88.95M | 88.04M | 86.88M | 84.33M | 74.87M | 63.88M | 47.18M | 33.58M | 25.54M | 15.91M | 9.15M | 4.31M | 1.63M | 998K | 929K | 944K | 1.07M | 1.56M |
Pretax Income | -812.81M | -698.26M | -600.85M | -566.72M | -522.73M | -487.8M | -439.89M | -335.33M | -296.65M | -259.58M | -249.13M | -245.17M | -224.49M | -207.56M | -187.09M | -168.26M | -142.54M | -125.51M |
Net Income | -812.06M | -697.51M | -600.09M | -567.06M | -519.21M | -484.27M | -436.37M | -331.34M | -296.23M | -259.16M | -248.71M | -244.87M | -224.49M | -207.56M | -187.09M | -168.62M | -142.9M | -125.82M |
Selling & General & Admin | 127.77M | 108.9M | 96.72M | 87.15M | 78.71M | 71.64M | 62.02M | 54.29M | 49.21M | 44.77M | 40.59M | 38.37M | 35.72M | 32.82M | 30.45M | 27.58M | 25.13M | 22.93M |
Research & Development | 769.73M | 680.53M | 592.8M | 553.19M | 509.17M | 472.22M | 423.14M | 340.79M | 302.51M | 265.53M | 253.07M | 240.63M | 217.65M | 202.58M | 186.95M | 170.27M | 158.67M | 145.65M |
Other Expenses | -545.6M | -558.37M | -470.64M | -405.53M | -361.51M | -356.38M | -307.31M | -250.45M | -212.17M | -265.53M | -253.07M | -240.63M | -217.65M | -202.58M | -186.95M | -170.27M | -158.67M | -145.65M |
Operating Expenses | 351.9M | 231.05M | 218.88M | 234.81M | 226.36M | 187.47M | 177.86M | 144.63M | 139.55M | 44.77M | 40.59M | 38.37M | 35.72M | 32.82M | 30.45M | 27.58M | 25.13M | 22.93M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12K | 26K | 43K | 62K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 901.3M | 789.42M | 689.52M | 653.94M | 601.48M | 557.45M | 498.76M | 395.08M | 351.72M | 310.3M | 293.66M | 278.99M | 253.37M | 235.4M | 217.4M | 197.86M | 183.8M | 168.58M |
Income Tax Expense | -753K | -753K | -753K | 343K | -3.52M | -3.52M | -3.52M | -3.99M | -420K | -420K | -420K | -297K | n/a | n/a | n/a | 362K | 362K | 304K |
Shares Outstanding (Basic) | 188.15M | 188.15M | 167.74M | 166.84M | 165.14M | 164.73M | 141.18M | 109.23M | 106.88M | 94.83M | 89.16M | 84.69M | 74.28M | 74.16M | 73.82M | 73.54M | 73.4M | 70.42M |
Shares Outstanding (Diluted) | 188.15M | 188.15M | 167.74M | 166.84M | 165.14M | 164.73M | 141.18M | 109.23M | 106.88M | 94.83M | 89.16M | 84.69M | 74.28M | 74.16M | 73.83M | 73.54M | 73.4M | 70.42M |
EPS (Basic) | -4.33 | -4.01 | -3.58 | -3.59 | -3.64 | -3.75 | -3.67 | -3.16 | -3.04 | -2.93 | -3.08 | -3.16 | -3.01 | -2.8 | -2.56 | -2.37 | -2.07 | -1.93 |
EPS (Diluted) | -4.33 | -4.01 | -3.58 | -3.59 | -3.64 | -3.75 | -3.67 | -3.16 | -3.04 | -2.93 | -3.08 | -3.16 | -3.01 | -2.8 | -2.56 | -2.37 | -2.07 | -1.93 |
EBITDA | -883.71M | -776.65M | -677.7M | -594.3M | -542.57M | -495.75M | -430.28M | -354.78M | -307.78M | -260.51M | -243.54M | -240.13M | -217.22M | -199.92M | -179.75M | -161.26M | -135.65M | -118.77M |
EBIT | -897.5M | -789.42M | -689.52M | -605.6M | -553.14M | -505.29M | -439.59M | -363.83M | -317.12M | -270.41M | -253.2M | -249.25M | -225.65M | -207.86M | -187.08M | -168.23M | -142.5M | -125.45M |
Depreciation & Amortization | 13.78M | 12.78M | 11.82M | 11.29M | 10.56M | 9.54M | 9.31M | 9.05M | 9.34M | 9.9M | 9.66M | 9.12M | 8.44M | 7.94M | 7.33M | 6.97M | 6.85M | 6.68M |